Cargando…
Nonhormonal therapy for endometriosis: a randomized, placebo-controlled, pilot study of cabergoline versus norethindrone acetate
OBJECTIVE: To estimate the efficacy and safety of a novel nonhormonal therapeutic agent, cabergoline, compared with that of the standard clinical therapy, norethindrone acetate (NETA), for the treatment of endometriosis-associated pain in young women with endometriosis. DESIGN: Randomized, double-bl...
Autores principales: | DiVasta, Amy D., Stamoulis, Catherine, Gallagher, Jenny Sadler, Laufer, Marc R., Anchan, Raymond, Hornstein, Mark D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655411/ https://www.ncbi.nlm.nih.gov/pubmed/34934987 http://dx.doi.org/10.1016/j.xfre.2021.07.003 |
Ejemplares similares
-
Cohort profile: The Endometriosis pain QUality aftEr Surgical Treatment (EndoQUEST) Study
por: Shafrir, Amy L., et al.
Publicado: (2022) -
Norethindrone Acetate in the Medical Management of Adenomyosis
por: Muneyyirci-Delale, Ozgul, et al.
Publicado: (2012) -
Medical management of recurrent endometrioma with long-term norethindrone acetate
por: Muneyyirci-Delale, Ozgul, et al.
Publicado: (2012) -
Nonhormonal therapy for endometriosis based on energy metabolism regulation
por: Kobayashi, Hiroshi, et al.
Publicado: (2021) -
Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy
por: Soliman, Ahmed M., et al.
Publicado: (2016)